Ciprofloxacin Extended-Release Tablets and Dabigatran
Determining the interaction of Ciprofloxacin Extended-Release Tablets and Dabigatran and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ciprofloxacin
Brand name: Cipro, Cipro XR, Proquin XR, Cipro IV
Synonyms: Ciprofloxacin, Ciprofloxacin (Systemic)
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran Etexilate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ciprofloxacin Extended-Release Tablets-Dabigatran Etexilate
- Ciprofloxacin Extended-Release Tablets-Dabigatran Etexilate Mesylate
- Ciprofloxacin Extended-Release Tablets-Dabrafenib
- Ciprofloxacin Extended-Release Tablets-Dabrafenib Mesylate
- Ciprofloxacin Extended-Release Tablets-Dacarbazine
- Ciprofloxacin Extended-Release Tablets-Dacarbazine Intravenous, Injection
- Dabigatran-Ciprofloxacin in 5% Dextrose
- Dabigatran-Ciprofloxacin injection
- Dabigatran-Ciprofloxacin Injection Concentrate
- Dabigatran-Ciprofloxacin Intravenous
- Dabigatran-Ciprofloxacin Oral Suspension
- Dabigatran-Ciprofloxacin Tablets